Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,368.00    -33.50 (-0.76%)
Bid:
4,368.50
Ask:
4,369.00
Spread: 0.50 (0.011%)
Market Cap: £94.59b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Listing Rule 9.2.6E statement

27 Apr 2020 18:00

RNS Number : 0367L
Unilever PLC
27 April 2020
 

 

Unilever PLC announces that, pursuant to UK Listing Rule 9.2.6E, a document describing the rights attaching to its listed equity shares has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

 

 

 

Safe Harbour

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current COVID-19 pandemic. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2019 and the Unilever Annual Report and Accounts 2019.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCUBSNRRUUSUAR
Date   Source Headline
14th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20245:52 pmRNSDirector/PDMR Shareholding
11th Jun 20245:44 pmRNSDirector/PDMR Shareholding
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 202412:46 pmRNSTotal Voting Rights
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20245:42 pmRNSPUBLICATION OF UFN FINANCIAL STATEMENTS
31st May 20247:00 amRNSTransaction in Own Shares
30th May 202412:13 pmRNSDirector/PDMR Shareholding
30th May 20247:00 amRNSTransaction in Own Shares
29th May 202412:19 pmRNSDirector/PDMR Shareholding
29th May 20247:00 amRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSTransaction in Own Shares
22nd May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSTransaction in Own Shares
20th May 20247:00 amRNSTransaction in Own Shares
17th May 20241:58 pmRNSDirector/PDMR Shareholding
17th May 20247:00 amRNSShare Buy-Back Programme
8th May 20244:00 pmRNSDirector/PDMR Shareholding
1st May 20244:10 pmRNSResult of AGM
1st May 20243:17 pmRNSCommittee Composition
1st May 20249:06 amRNSTotal Voting Rights
25th Apr 20247:00 amRNSQ1 2024 Trading Statement
2nd Apr 20243:58 pmRNSTotal Voting Rights
28th Mar 20245:04 pmRNSDirector/PDMR Shareholding
27th Mar 202412:32 pmRNSDirector/PDMR Shareholding
26th Mar 20246:13 pmRNSDirector/PDMR Shareholding
26th Mar 202411:58 amRNSDirector/PDMR Shareholding
25th Mar 20243:10 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSUnilever to accelerate Growth Action Plan
18th Mar 20243:00 pmRNSNotice of AGM
14th Mar 20242:14 pmRNSAnnual Financial Report
13th Mar 20247:00 amRNSBlock Listing of Shares
11th Mar 20245:55 pmRNSDirector/PDMR Shareholding
1st Mar 20242:36 pmRNSTotal Voting Rights
19th Feb 20243:14 pmRNSDirector/PDMR Shareholding
8th Feb 20247:00 amRNSFinal Results
1st Feb 20245:04 pmRNSTotal Voting Rights
31st Jan 20243:00 pmRNSDirectorate Change
16th Jan 20245:10 pmRNSBlock listing Interim Review
2nd Jan 20242:54 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.